Loading
Latest filing published 17 Oct 2018 for Vodis Pharmaceuticals Inc., €1,255.
No signal scores available.
Mark Lotz appears in our data through filings on Vodis Pharmaceuticals Inc. shares, published by SEDI. Between 11 October 2016 and 15 October 2018, the trades on record add up to 4 filings.
No open-market purchase appears, only 1 sale worth €1,255. In 2018 alone, the filings show no purchases and 1 sale.
The record was last updated on 17 October 2018 with an open-market sale (€1,255) in Vodis Pharmaceuticals Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.